Jacobsen Biotech ApS: Financial statements 2025
CVR: 43211218
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Jacobsen Biotech ApS (CVR 43211218) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -7,890 and a net result of DKK -7,890 compared with DKK -2,872 the year before. Equity in the 2025 report amounted to DKK 14,103. The solvency ratio was 73.8%.
- Gross Profit
- DKK -7,890
- Profit/Loss
- DKK -7,890
- Equity
- DKK 14,103
- Total Assets
- DKK 19,103
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -8 t. | -8 t. | 14 t. | 0 |
| 2024 | 0 | 0 | -3 t. | 22 t. | - |
| 2023 | 4 t. | -15 t. | -18 t. | 25 t. | - |
Official annual report
How creditworthy is Jacobsen Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Jacobsen Biotech ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -2,872.
About Jacobsen Biotech ApS
Jacobsen Biotech ApS is a Danish company of the type Anpartsselskab based in Harlev J, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Kristian Mark Jacobsen. The company is owned by Kristian Mark Jacobsen. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK -7,890 and a net result of DKK -7,890 compared with DKK -2,872 the year before. Equity in the 2025 report amounted to DKK 14,103.